Otsuka Corporation (TYO:4768)
Japan
· Delayed Price · Currency is JPY 3,158.00
-22.00 (-0.69%)
At close: Dec 5, 2025
Otsuka Employees
Otsuka had 9,680 employees as of December 31, 2024. The number of employees increased by 472 or 5.13% compared to the previous year.
Employees
9,680
Change
472
Growth
5.13%
Revenue / Employee
133.38M JPY
Profits / Employee
6.55M JPY
Market Cap
1,197.52B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sony Group | 112,300 |
| Advantest | 7,001 |
| Tokyo Electron | 19,573 |
| Nintendo | 8,205 |
| Keyence | 12,261 |
| NEC Corporation | 104,194 |
| Fujitsu | 112,743 |
| Murata Manufacturing | 72,572 |
Otsuka News
- 9 days ago - FDA Approves Otsuka's (OTSKF) Voyxact for IgAN Treatment - GuruFocus
- 9 days ago - Otsuka gains FDA approval for sibeprenlimab for proteinuria reduction - Seeking Alpha
- 10 days ago - FDA Grants Accelerated Approval For Otsuka's VOYXACT In IgAN - Nasdaq
- 5 weeks ago - Otsuka 9-month Profit Rises; Revenue Up 5.1% - Nasdaq
- 5 months ago - Otsuka’s PTSD therapy draws efficacy concerns at FDA ahead of AdCom meeting - Seeking Alpha
- 5 months ago - SeaStar Medical's QUELIMMUNE Wins Prestigious Award From The National Kidney Foundation, Former Winners Include Names Like Janssen, Merck and Otsuka - Benzinga
- 6 months ago - Vera plunges as Otsuka outperforms with IgA nephropathy therapy - Seeking Alpha
- 6 months ago - Otsuka Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy (IgAN) - Benzinga